Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,525 JPY | +0.73% | +2.25% | -9.55% |
May. 01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
May. 01 | Poseida Therapeutics Shares Rise 18% After Licensing Deal With Xyphos Biosciences | DJ |
ETFs positioned on Astellas Pharma Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.47% | 15 M€ | +11.00% | ||
2.09% | 251 M€ | +13.17% | ||
2.01% | 57 M€ | +21.78% | ||
1.99% | 11 M€ | +13.81% | - | |
1.65% | 174 M€ | -.--% | - | |
1.65% | 51 M€ | -.--% | - | |
1.61% | 15 M€ | +16.45% | ||
1.31% | 31,732 M€ | +15.24% | - | |
1.30% | 1,198 M€ | +14.43% | - | |
1.22% | 81 M€ | +16.22% | ||
1.20% | 4 M€ | +16.67% | ||
1.19% | 67,864 M€ | +15.20% | ||
1.18% | 16,729 M€ | +14.30% | - | |
1.12% | 73 M€ | +16.75% | ||
0.94% | 60 M€ | +16.48% | ||
0.89% | 10,207 M€ | +16.22% | ||
0.89% | 5,115 M€ | +16.46% | ||
0.89% | 14 M€ | +18.86% | ||
0.75% | 18 M€ | +16.15% | - | |
0.67% | 26 M€ | +21.71% | ||
0.65% | 66,066 M€ | +16.60% | - | |
0.65% | 144,586 M€ | +16.45% | ||
0.65% | 20,721 M€ | +15.36% | - | |
0.42% | 717 M€ | +5.83% | ||
0.35% | 4 M€ | -.--% | - | |
0.35% | 1,120 M€ | -0.18% | ||
0.30% | 469 M€ | -2.05% | - | |
0.30% | 3,859 M€ | +18.82% | - | |
0.15% | 10 M€ | -3.35% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.55% | 17.24B | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- 4503 Stock
- Funds and ETFs Astellas Pharma Inc.